30 HUDSON STREET, JERSEY CITY, NJ
Audit Committee Review Completed; No Action Required on Biosimilars Purchases
Earnings Release
Third Quarter 2025 Earnings
Director Departure - Grace Puma Will Not Stand for Re-Election
Amended material disclosure
Appoints Executive Joseph Morrissey as Interim CEO and Board Chair Carrie Cox as Executive Chair; Announces Results of Audit Committee Investigation
Reports Results for the Second Quarter
News
FY 2024
Amended Quarterly Report
Q3
Amended Annual Report
Q2
Q1
FY 2023
Registration Statement for Securities to be Offered to Employees
Certificate
Amended Direct Registration System
Direct Registration System
Definitive Proxy Statement
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Specialized Disclosure Report
Submission Upload
Correspondence